Abbott Laboratories (ABT) Divestments (2015 - 2021)

Abbott Laboratories (ABT) has 5 years of Divestments data on file, last reported at $86.0 million in Q3 2021.

• For the quarter ending Q3 2021, Divestments changed N/A year-over-year to $86.0 million; the trailing twelve-month figure through Dec 2022 stood at $86.0 million (down 10.42% YoY), and the FY2024 full-year result was $1.0 million, down 97.5% from the prior year.
• Divestments grew to $86.0 million in Q3 2021, from $10.0 million in the prior quarter.
• In the past five years, Divestments ranged from a high of $5.5 billion in Q1 2017 to a low of -$29.0 million in Q3 2017.
• A 3-year average of $1.0 billion and a median of $48.0 million in 2020 frame the typical range for Divestments.
• Peak annual rise in Divestments reached 21788.0% in 2017, while the deepest fall reached 21788.0% in 2017.
• Tracing ABT's Divestments over 3 years: stood at $600.0 million in 2017, then tumbled by 98.33% to $10.0 million in 2020, then jumped by 760.0% to $86.0 million in 2021.
• Business Quant data shows ABT's Divestments at $86.0 million in Q3 2021, $10.0 million in Q4 2020, and $600.0 million in Q4 2017.